Ann: Conference Data Demonstrating Consistency of Cynata MSCs, page-20

First 20 Last

Share
Profile

Follow
Rossi70

4,419 Posts.

1573

17/11/22

16:49

Post #: 64837852
Share

Originally posted by Bazsa: ↑

"More Predictable"

Thats a intersting comment.

So why is there no undisputable data , after all if the cells were predictable it should be easy to prove benifit. But no clinical benifit has been shown after 150 patients been treated. That would indicate ether the cells do not work or they do but only in a very small population that remain unknown.

DFU The only conclution one can make is that the cells seem safe , I would be surprised if the DSMB were tasked to look at efficacy.

I was surprised at the progress made with the OA trial however if it is allowed to run its full length resaults will remain unknown till mid 26- 27. The half way point is now very close and this could triger a review by the DSMB. The recomendation to continue as planed would be a very big relief to the market as the outcome is at a pivotal point. But what if they stoped the trial? A single didget SP while investors hope for a more positive outcome for DFU.

Expand

Hi Bazsa,

If you are after Further information, about how good CYP cells are, then the only advice I can give you, is just give Fuji Film a call.

In relation to the O.A. trial, then why are CYP conducting currently a Phase 3 trial and not a Phase 1 trial.

IMHO.

Regards

Rossi70

CYP Price at posting: 35.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

HotCopper's got a new owner: UK-based fintech ADVFN Ltd

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

BM8

'Lead role in European tech metals' beckons for BM8 as Bleiberg drills rumble to life

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 20 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.0¢		Change -0.010(5.88%)		Mkt cap ! $37.28M

Open	High	Low	Value	Volume
17.0¢	18.0¢	16.0¢	$65.91K	388.6K

Buyers (Bids)

No.	Vol.	Price($)
5	60640	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	109002	2

View Market Depth

No.	Vol.	Price($)
2	62977	0.160
5	60640	0.155
6	166873	0.150
2	5200	0.145
2	45000	0.140

Price($)	Vol.	No.
0.165	269997	2
0.170	99109	2
0.180	50882	2
0.185	51358	4
0.195	21950	2

Last trade - 12.30pm 30/06/2025 (20 minute delay)

CYP (ASX) Chart

Ann: Conference Data Demonstrating Consistency of Cynata MSCs, page-20

HotCopper's got a new owner: UK-based fintech ADVFN Ltd

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Lead role in European tech metals' beckons for BM8 as Bleiberg drills rumble to life

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Conference Data Demonstrating Consistency of Cynata MSCs, page-20

Top Stories

HotCopper's got a new owner: UK-based fintech ADVFN Ltd

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Lead role in European tech metals' beckons for BM8 as Bleiberg drills rumble to life

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News